Chairs Scientific Sessions (in alphabetical order)
David Adams, Université Paris Saclay, Paris, France
Kerstin Amann, University Hospital, Erlangen, Germany
Vittorio Bellotti, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Norbert Blank, Amyloidosis Center of the University Hospital, Heidelberg, German
Alexander Carpinteiro, Amyloidosis Center of the University Hospital, Essen, Germany
Maite Cibeira, Amyloidosis and Myeloma Unit, Barcelona, Spain
Thibaud Damy, Henri Mondor University Hospital, Créteil, France
Sharmila Dorbala, Brigham and Women’s Hospital, Boston, USA
Carlos Fernández de Larrea, Amyloidosis and Myeloma Unit, Barcelona, Spain
Sophie Georgin-Lavialle, Sorbonne University, Paris, France
Ute Hegenbart, host ISA 2022, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Efstathios Kastritis, National and Kapodistrian University, Athens, Greece
Shaji Kumar, Mayo Clinic, Rochester, Minnesota, USA
Nelson Leung, Mayo Clinic, Rochester, USA
Matthew Maurer, Columbia University, New York, USA
Paolo Milani, Amyloidosis Research and Treatment Center, University of Pavia and IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Monique Minnema, University Medical Center, Utrecht, Netherlands
Gareth Morgan, Amyloidosis Center at Boston University School of Medicine, Boston, USA
Hironobu Naiki, University of Fukui, Fukui, Japan
Giovanni Palladini, ISA president, Amyloidosis Research and Treatment Center, University of Pavia and IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Marina Ramirez-Alvarado, Mayo Clinic, Rochester, USA
Stefano Ricagno, Università di Milano, Milano, Italy
Eloisa Riva, Hospital de Clínicas “Dr. Manuel Quintela”, Montevideo, Uruguay
Christoph Röcken, University Hospital, Kiel, Germany
Vaishali Sanchorawala, Amyloidosis Center at Boston University School of Medicine, Boston, USA
Matthias Schmidt, University Ulm, Ulm, Germany
Stefan Schönland, host ISA 2022, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Fabian aus dem Siepen, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Marcia Waddington-Cruz, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Ashutosh Wechalekar, National Amyloidosis Centre, London, United Kingdom
Gunilla Westermark, Uppsala University, Uppsala, Sweden
And ISA 2022 Organizing Committee
Chairs Poster Sessions
Poster Session Monday
AL amyloidosis
Vaishali Sanchorawala, Amyloidosis Center at Boston University School of Medicine, Boston, USA
Paolo Milani, Amyloid Research and Treatment Center, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Maite Cibeira, Amyloidosis and Myeloma Unit, Barcelona, Spain
Timon Hansen, Haematology-Oncology Clinic, Altona, Hamburg, Germany
Hermine Agis, Department of Medicine, Medical University of Vienna, Vienna, Austria
Angela Dispenzieri, Mayo Clinic, Rochester, USA
Jeffrey Zonder, Karmanos Cancer Institute, Detroit, USA
ATTRwt amyloidosis
Thibaud Damy, Henri Mondor University Hospital, Créteil, France
Matthew Maurer, Columbia University, New York, USA
Pablo Garcia-Pavia, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Maria Papathanasiou, University Hospital Essen, Germany
ATTRv amyloidosis
Marcia Waddington-Cruz, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Katrin Hahn, Amyloidosis Center, Charité, Berlin, Germany
Isabel Maria Conceicao, Centro Hospitalar Universitário Lisboa Norte – Hospital de Santa Maria, Lisboa, Portugal
Markus Weiler, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Poster Session Tuesday
Fibril and Amyloid Formation
Mario Nuvolone, Amyloidosis Research and Treatment Center, University of Pavia and IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Christoph Röcken, University Hospital, Kiel, Germany
Joost Schymkowitz, Leuven Center for Brain & Disease Research, Leuven, Belgium
Mechanism of organ dysfunction and damage
Marina Ramirez-Alvarado, Mayo Clinic, Rochester, USA
Stefano Ricagno, Università di Milano, Milano, Italy
Pre-clinical disease models
Gunilla Westermark, Uppsala University, Uppsala, Sweden
Alexander Carpinteiro, University Hospital Essen, Germany
Imaging
Simon Gibbs, The Victorian and Tasmanian Amyloidosis Service, Australian Amyloidosis Network, Australia
Jennifer Hayes, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Jonathan Wall, University of Tennessee, Knoxville, USA
Martha Grogan, Mayo Clinic, Rochester, USA
Late Breaking Abstracts
Suzanne Lentzsch, Columbia University, New York, USA
Per Westermark, Uppsala University, Uppsala, Sweden
Poster Session Wednesday
Pathway to Diagnosis
Eli Muchtar, Mayo Clinic, Rochester, USA
Rahel Schwotzer, University Hospital, Zurich, Switzerland
Fabian aus dem Siepen, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Eloisa Riva, Hospital de Clínicas “Dr. Manuel Quintela”, Montevideo, Uruguay
Sandra Ihne, Amyloidosis Center, University Hospital Würzburg, Germany
Hans Nienhuis, Amyloidosis Centre of Expertise, University Medical Center, Groningen, Netherlands
Kerstin Amann, University Hospital, Erlangen, Germany
Hironobu Naiki, University of Fukui, Fukui, Japan
Arnaud Jaccard, CHU, Limoges, France
AA Amyloidosis
Norbert Blank, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Biology, Clinics and Therapeutics in other types of amyloidosis
Laura Obici, Amyloidosis Research and Treatment Center, University of Pavia and IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Ernst Hund, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Innovative Therapies
Efstathios Kastritis, National and Kapodistrian University, Athens, Greece
Gareth Morgan, Amyloidosis Center at Boston University School of Medicine, Boston, USA
Peter Mollee, Princess Alexandra Hospital, Brisbane, Queensland, Australia